tirzepatide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42413499
Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease.
Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease.
- 저자
- Anika Vear, Sofie Amalie Olsen, Emilie Cathrine Holst Lange, Marie Amalie Müller, Charlotte Svendsen, Christoffer Clemmensen
- 저널
- Cell reports. Medicine
- 공개일
- 2026 Jul 21
- 연구 유형
- 기타
- DOI
- 10.1016/j.xcrm.2026.102906
문헌 요약
There is growing evidence that long-acting mimetics of the gut-derived incretin hormones GLP-1 and GIP act as disease-modifying therapies for Alzheimer's disease (AD). Here, we temporally characterize the efficacy of the approved incretin receptor agonists semaglutide, a GLP-1R agonist, and tirzepatide, a GLP-1R/GIPR co-agonist, in preventing AD progressi…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.